SCM
REGN icon

Stux Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Stux Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$876K Sell
3,100
-700
-18% -$207K 0.11% 227
2014
Q1 		$1.14M Sell
3,800
-300
-7% -$92.4K 0.14% 194
2013
Q4 		$1.13M Buy
4,100
+200
+5% +$57.5K 0.13% 187
2013
Q3 		$1.22M Sell
3,900
-600
-13% -$158K 0.16% 177
2013
Q2 		$1.01M Buy
+4,500
New +$1.05M 0.13% 197

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stux Capital Management's REGN Position: Q2 2014 in Review

Stux Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2014, selling an estimated $207K and leaving 3,100 shares worth $876K. The position accounts for 0.11% of the portfolio, ranked #227.

Stux Capital Management first reported a position in REGN in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.22M in Q3 2013. 448 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

  • Stux Capital Management held 3,100 shares of Regeneron Pharmaceuticals worth $876K as of Q2 2014.
  • Stux Capital Management sold 700 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $207K.
  • Regeneron Pharmaceuticals made up 0.11% of Stux Capital Management's portfolio in Q2 2014, its #227 holding.
  • Stux Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
  • Stux Capital Management's Regeneron Pharmaceuticals position peaked at $1.22M in Q3 2013.
  • 448 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.